Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04961047 · ClinicalTrials.gov registry record · NA
Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04961047 is a NA study that has completed, run by Yale University. The registered enrollment target is 36 participants.
The verdict
NCT04961047, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a prospective, randomized clinical study to evaluate the feasibility and efficacy of a digital neurotherapy on depression, cognition, and quality of life in two groups of patients with major medical illness: 1) a sample of cancer survivors, and 2) a sample of patients with end stage kidney disease (ESKD) on dialysis.
Interventions
- BEHAVIORAL Wait list control group
- BEHAVIORAL Digital neurotherapy (DNT) Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04961047
The ClinicalTrials.gov registry entry for NCT04961047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wait list control group is the first listed.
NCT04961047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04961047 about?
NCT04961047 is a clinical study titled "Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors". This is a prospective, randomized clinical study to evaluate the feasibility and efficacy of a digital neurotherapy on depression, cognition, and quality of life in two groups of patients with major medical illness: 1) a sample of cancer survivors, and 2) a sample of patients with end stage kidney d...
What is the current status of trial NCT04961047?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-12-17. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT04961047?
The interventions under investigation include: Wait list control group (BEHAVIORAL), Digital neurotherapy (DNT) Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04961047?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.